Pages
Products
U6-shRNA-GFP AAV (Serotype 5)

U6-shRNA-GFP AAV (Serotype 5)

Cat.No. :  AAV00085Z

Titer: ≥1x10^12 GC/mL / ≥1x10^13 GC/mL Size: 30 ul/100 ul/500 ul/1 ml

Serotype:  AAV Serotype 5 Storage:  -80 ℃

Inquire for Price

AAV Particle Information

Quality Control

Cat. No. AAV00085Z
Description U6-shRNA-GFP AAV (Serotype 5) is the serotype 5 AAV which expresses scramble shRNA under U6 promoter with co-expression of GFP as reporter under CMV promoter. This product used in the gene knockdown experiments as a control in cultured cells and animal experiments.
Serotype AAV Serotype 5
Target Gene U6-shRNA-GFP
Product Type Adeno-associated virus
Titer Varies lot by lot, typically ≥1x10^12 GC/mL
Size Varies lot by lot, for example, 30 μL, 50 μL, 100 μL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Creative Biogene ensures high-quality AAV particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between AAV particle lots.
Endotoxin Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in the production of AAV, especially for applications in animal studies and gene therapy. Effective endotoxin quality control is essential in the development and manufacturing of AAV particles. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced AAV particles to ensure regulatory compliance.
Purity AAV purity is critical for ensuring the safety and efficacy of AAV-based applications.AAV capsids are composed of three main protein components, known as viral proteins: VP1, VP2, and VP3. These proteins play a critical role in the structure and functionality of the AAV capsid. Monitoring the VP1, VP2, and VP3 content in AAV preparations is essential for quality control in AAV production. Our AAV particles are tested for showing three clear bands of VP1, VP2 VP3 by SDS-PAGE.
Sterility The AAV virus samples are inoculated into the cell culture medium for about 5 days to detect bacterial and fungal growth.
Transducibility Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of AAV to deliver genetic material into target cells or tissues, and assess gene expression and functional activities.
Empty vs. Full Capsids Based-on our proprietary AAV production and purification technology, Creative Biogene can always offer AAV particles with high ratio of full capsids. If required, we can also assess the ratio for a specifc lot of AAV particles by transmission electron microscopy (TEM) or other methods.
Quick Inquiry

Background

Publications

Q & A

Customer Reviews

Recombinant adeno-associated viruses (rAAV) are promising viral vectors for gene delivery applications. These viruses belong to the single-stranded DNA (ssDNA)-packaged Parvoviridae and Dependovirus genera. Hundreds of AAV genotypes have been sequenced from several mammalian species, and to date, 12 serotypes (AAV1 to AAV12) have been defined for human and non-human primate isolates. Based on antigenic reactivity and sequence similarity, these 12 serotypes are divided into eight genotypes, clades A to F and clonal isolates AAV4 and AAV5. These groups are represented by AAV1 to AAV9, with AAV1 and AAV6 belonging to the same clade A due to their high sequence similarity and antigenic cross-reactivity. The sequence identity of representative members ranges from about 55% to 99%, with AAV4 and AAV5 being the most divergent from each other and from other members. U6-shRNA-GFP AAV (serotype 5) is a versatile and widely used molecular biology tool, especially in gene knockdown experiments. The U6 promoter is a strong and ubiquitous promoter that is primarily used to drive the expression of small RNA molecules such as shRNA in mammalian cells. The choice of random shRNA is critical because it serves as a non-targeting control. This ensures that any effects observed in the experimental setting are due to specific shRNA-mediated gene silencing rather than off-target or non-specific effects, thus providing a more accurate interpretation of the gene knockdown results.
Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Excellent for Gene Knockdown Control

The U6-shRNA-GFP AAV (Serotype 5) has been an invaluable tool in my gene knockdown experiments. Its consistent expression levels and robustness make it the perfect control choice.

United Kingdom

01/25/2022

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction